Kawasaki et al. examined the relationship between insulin-like growth factor binding protein 3 (IGFBP3) methylation, p53 expression, CIMP, and MSI in 902 population-based colorectal cancers [36]. This evidence concerns the gene TP53 and colorectal cancer.